Back to London in March 2022, Cevidra team will attend to the 8th RWE, Market Access, Pricing & Reimbursement Congress co-located with the Expanded Access Programmes Global Congress.
The conferences will focus on critical issues that shape the future of European Market Access.
We will meet with stakeholders from industry (government, pharmaceuticals, biotech non-profits, research organizations) as well as patient groups and advocates.
We would love to hear from anyone else in attendance who may have questions on any of these topics.
Feel free to contact us.
